Habitual key facts
as of Oct 2026- Operator of a digital therapeutics platform intended to end diabetes by introducing a prevention and reversal program.
- Habitual is valued at approximately $7.5M as of Oct 2026 (last reported valuation).
- It has raised $6.3M; the latest was Later Stage VC ($1.3M) in Apr 2025.
- Notable investors include Seedcamp, MMC Ventures, Noaber Ventures, Food Labs, Leanox Impact Capital — 10 tracked in total.
- Status: Privately Held (backing).
Habitual's last reported valuation, Oct 2021. Nothing priced has surfaced since.
- ·Watch Habitual: the Monday email on marks, rounds and moves
Habitual funding rounds
No funding rounds for Habitual are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Habitual valuation
Habitual's last reported valuation was $7.5 million in Oct 2021. No priced round, secondary trade or fund mark has surfaced since.
Habitual investors
10 investors are on record for Habitual, including Seedcamp, MMC Ventures, Noaber Ventures and Food Labs.
About Habitual
Operator of a digital therapeutics platform intended to end diabetes by introducing a prevention and reversal program. The company's platform provides digital therapeutics for weight loss by combining digital habit change with a nutritionally complete food product, enabling patients to avail themselves of therapeutic weight loss assistance.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2019
- Employees
- 25
- Website
- tryhabitual.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.